An interventional study to access the effect of Ayurvedic medicine ASA-20 as a prohylaxis in high risk population exposed to COVID-19
- Registration Number
- CTRI/2020/06/026055
- Lead Sponsor
- Ministry of AYUSH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Subjects of high risk population
2 Male or female subjects above the age of 15 years to 70 years.
3 Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study.
1 Pregnant and Lactating woman
2 Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening.
3 Subjects who are on any regular medication(alternative/modern) for any other ailments.
4 Subjects participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study.
5 Subjects having a past history of allergy to any medicine that is part of the Ayurvedic intervention. Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrollment or could interfere with his participation in, and completion of the protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the occurrence of COVID-19 infection in healthy volunteers exposed to COVID-19 in the communityTimepoint: 6 MONTHS
- Secondary Outcome Measures
Name Time Method 1 To assess the immunity status of the participants taking ASA-20. <br/ ><br>2 To evaluate the occurrence of adverse event for safety assessment of ASA-20. <br/ ><br>Timepoint: 6 MONTHS